Cancer Immune Therapy Edited by G. Stuhler and P. Walden ...

92 5 Major Histocompatibility Complex Modulation and Loss
77 Riker AI, Kammula US, Panelli MC,
Wang E, Ohnmacht GA, Steinberg
SM, Rosenberg SA, Marincola FM.
Int J Cancer 2000; 86: 818±826.
78 Sykulev Y, Joo M,Virturina I, Tsomides
TJ, Eisen HN. Immunity 1996;
4: 565±571.
79 Cormier JN, Panelli MC, Hackett
JA, Bettinotti MP, Mixon A, Wunderlich
J, Parker LL, RestifoNP,
Ferrone S, Marincola FM. Int J Cancer
1999; 80: 781±790.
80 Ljunggren HG, Kårre K. J Exp Med
1985; 162: 1745±1759.
81 Ohnmacht GA, Marincola FM. J Cell
Physiol 2000; 182: 332±338.
82 Alimonti J, Zhang QJ, Gabathuler
R, Reid G, Chen SS, Jeffries
WA. Nat Med 2000; 18: 515±520.
83 Zemmour J, Little AM, Schendel DJ,
Parham P. J Immunol 1992; 148: 1941±
1948.
84 Wang Z, Seliger B, Mike N, Momburg
F, Knuth A, Ferrone S. Cancer
Res 1998; 58: 2149±2157.
85 Wælfel T, Klehmann E, Mçller C,
Schçtt KH, Meyer-zum-Bçschenfelde
KH, Knuth A. J Exp Med 1989;
170: 797±810.
86 Lehmann F, Marchand M, Hainaut P,
Pouillart P, Sastre H, Ikeda H,
Boon T, Coulie PG. Eur J Immunol
1995; 25: 340±347.
87 Cabrera T, Fernandez MA, Sierra A,
GarridoA, HerruzzoA, EscobedoA,
Fabra A, GarridoF. Hum Immunol
1996; 50: 127±134.
88 Wang Z, Marincola FM, Rivoltini L,
Permiani G, Ferrone S. J Exp Med
1999; 190: 205±213.
89 Zia A, Schildberg FW, Funke I. Int J
Cancer 2001; 93: 566±570.
90 Shen L, Chiang AK, Liu WP, Li GD,
Liang RH, Srivastava G. Int J Cancer
2001; 92: 692±696.
91 Harada H, Kondo T, Ogawa S, Tamura
T, Kitawaga M, Tanaka N,
Lamphier MS, Hirai H, Taniguchi T.
Oncogene 1994; 9: 3313±3320.
92 Fujita T, Sakakibara J, SudoY, MiyamatoM,
Kimura Y, Taniguchi T.
EMBO J 1988; 7: 3397±3405.
93 Hallermalm K, Seki K,Wei C, Castelli
C, Rivoltini L, Kiessling R, Levitskaya
J. Blood 2001; 98: 1108±1115.
94 Qi L, Rojas J-M, Ostrand-Rosenberg
S. J Immunol 2000; 165: 5451±
5461.
95 Blanck G. Microbe Infect 1999; 1: 913±
918.
96 YaoY, Minter HA, Chen X, Reynolds
GM, Bromley M, Arrand JR. Int J
Cancer 2000; 88: 949±955.
97 Bosshart H, Jarrett RF. Blood 1998;
7: 2252±2259.
98 Magnusson PKE, Euroth H, Eriksson
I, Held M, Nyren O, Engstan
Hansson LE, Gyllenstein UB. Cancer
Res 2001; 61: 2684±2689.
99 Moretti S, Pinzi C, Berti E, Spallanzani
A, Chiarugi A, Boddi V, Reali
UM, Giannotti B. Melanoma Res 1997;
7: 313±321.
100 Concha A, Esteban F, Cabrera T,
Ruiz-CabelloF, GarridoF. Semin Oncol
1991; 2: 47±54.
101 Trieb K, Lechleitner T, Lang S,
Windhager R, Kotz R, Dirnhofer S.
Pathol Res Pract 1998; 194: 679±684.
102 Cromme FV, von Bommel PF,Walboomers
JM, Gallee MP, Stern PL, Kenemans
P, Helmerhorst TJ, Stukart MJ,
Meijer CJ. Br J Cancer 1994; 69: 1176±
1181.
103 Matsushita K, Takenouchi T, Kobayashi
S, Hayashi H, Okuyama K,
Ochiai T, Mikata A, Isono K. Br J
Cancer 1996; 73: 644±648.
104 Norheim Andersen S, Breivik J, Lovig
T, Meling GI, Gaudernack G,
Clausen OP, Schjolberg A, Fausa O,
Langmark F, Lund E, Rognum TO.
Br J Cancer 1996; 74: 99±108.
105 Sikorska B, Danilewicz M, Wagrowska-Danilewicz
M. APMIS 1999; 107:
383±388.
106 Brunner C, Gokel J, Riethmçller G,
Johnson J. Eur J Cancer 1991; 27: 411±
416.
107 AlbinoAP, Nanus DM, Mentle IR,
Cordon-Cardo C, McNutt NS, Bressler
J, Andreeff M. Oncogene 1992; 7:
2315±2321.
108 Morris AC, Spangler WE, Boss JM.
J Immunol 2000; 164: 4143±4149.